Works matching IS 01676806 AND DT 2025 AND VI 209 AND IP 2


Results: 22
    1
    3
    4
    5
    6
    7
    8
    9
    10

    70-Gene signature-guided adjuvant systemic treatment adjustments in early-stage ER+ breast cancer patients: 7-year follow-up of a prospective multicenter cohort study.

    Published in:
    Breast Cancer Research & Treatment, 2025, v. 209, n. 2, p. 331, doi. 10.1007/s10549-024-07496-3
    By:
    • Verreck, Eline E. F.;
    • Kuijer, Anne;
    • van Steenhoven, Julia E. C.;
    • Volders, José H.;
    • van der Velden, Annette W. G.;
    • Siesling, Sabine;
    • Timmer-Bonte, Anja N. H.;
    • Smilde, Tineke J.;
    • Imholz, Alex L. T.;
    • Blanken-Peeters, Charlotte F. J. M.;
    • de Valk, Bart;
    • Vrijaldenhoven, Suzan;
    • Lastdrager, Willem B.;
    • Haringhuizen, Annebeth W.;
    • Hunting, Jarmo C. B.;
    • Hovenga, Sjoerd;
    • Nieboer, Peter;
    • Zuetenhorst, Hanneke M.;
    • Tetteroo, Geert W. M.;
    • Smorenburg, Carolien H.
    Publication type:
    Article
    11

    Genomic and transcriptomic landscape of HER2-low breast cancer.

    Published in:
    Breast Cancer Research & Treatment, 2025, v. 209, n. 2, p. 323, doi. 10.1007/s10549-024-07495-4
    By:
    • Bansal, Rani;
    • Adeyelu, Tolulope;
    • Elliott, Andrew;
    • Walker, Phillip;
    • Bustos, Matias A.;
    • Rodriguez, Estelamari;
    • Accordino, Melissa K.;
    • Meisel, Jane;
    • Gatti-Mays, Margaret E.;
    • Hsu, Emily;
    • Lathrop, Kate;
    • Kaklamani, Virginia;
    • Oberley, Matthew;
    • Sledge, George;
    • Sammons, Sarah L.;
    • Graff, Stephanie L.
    Publication type:
    Article
    12

    Attrition between lines of therapy and real-world outcomes of patients with HER2-positive metastatic breast cancer in Europe: a cohort study leveraging electronic medical records.

    Published in:
    Breast Cancer Research & Treatment, 2025, v. 209, n. 2, p. 419, doi. 10.1007/s10549-024-07506-4
    By:
    • Cottu, Paul;
    • Cheeseman, Sue;
    • Hall, Peter;
    • Wöckel, Achim;
    • Scholz, Christian W.;
    • Bria, Emilio;
    • Orlandi, Armando;
    • Ribelles, Nuria;
    • Vallet, Mahéva;
    • Niklas, Nicolas;
    • Hogg, Catherine;
    • Aggarwal, Shivani;
    • Moreira, Joana;
    • Lucerna, Markus;
    • Collin, Simon M.;
    • Logue, Amanda;
    • Long, Gráinne H.
    Publication type:
    Article
    13
    14
    15

    BRCA promoter methylation in triple-negative breast cancer is preserved in xenograft models and represents a potential therapeutic marker for PARP inhibitors.

    Published in:
    Breast Cancer Research & Treatment, 2025, v. 209, n. 2, p. 389, doi. 10.1007/s10549-024-07502-8
    By:
    • Däster, Kavitha;
    • Hench, Jürgen;
    • Diepenbruck, Maren;
    • Volkmann, Katrin;
    • Rouchon, Adelin;
    • Palafox, Marta;
    • Miragaya, Jorge Gomez;
    • Preca, Bogdan Tiberius;
    • Kurzeder, Christian;
    • Weber, Walter Paul;
    • Bentires-Alj, Mohamed;
    • Soysal, Savas Deniz;
    • Muenst, Simone
    Publication type:
    Article
    16
    17
    18
    19
    20
    21

    Germline genetic mutations in a multi-center cohort of 248 phyllodes tumors.

    Published in:
    Breast Cancer Research & Treatment, 2025, v. 209, n. 2, p. 275, doi. 10.1007/s10549-024-07488-3
    By:
    • Rosenberger, Laura H.;
    • Thomas, Samantha M.;
    • Hieken, Tina J.;
    • Gallagher, Kristalyn K.;
    • Spanheimer, Philip M.;
    • Neuman, Heather B.;
    • Weiss, Anna C.;
    • King, Tari A.;
    • Wong, Jasmine;
    • Tong, Barry S.;
    • Nash, Amanda L.;
    • Frazier, Margaret Powell;
    • Menendez, Carolyn S.;
    • Hwang, E. Shelley;
    • Jakub, James W.;
    • Plichta, Jennifer K.
    Publication type:
    Article
    22